-+ 0.00%
-+ 0.00%
-+ 0.00%

Anika Therapeutics Raises FY2026 Sales Guidance from $118.460M-$124.101M to $119.588M-$124.101M vs $121.639M Est

Benzinga·11/06/2026 12:06:16
Listen to the news
Anika Therapeutics (NASDAQ:ANIK) raises FY2026 sales outlook from $118.460 million-$124.101 million to $119.588 million-$124.101 million vs $121.639 million estimate.